Aydin H. Pooli

Aydin H. Pooli

Urology
12021 Wilmington Ave
Los Angeles, CA 90059

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical Trial.

Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical Trial.

Journal: European urology oncology
Published: August 12, 2025

Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma.

Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma.

Journal: Cancer investigation
Published: February 05, 2024

Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena.

Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena.

Journal: Journal of hematology & oncology
Published: January 21, 2022

Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings.

Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings.

Journal: The Journal of urology
Published: October 07, 2020

Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier.

Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier.

Journal: European urology
Published: May 15, 2020

Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study.

Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study.

Journal: European urology oncology
Published: March 17, 2020

Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors.

Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors.

Journal: Urologic oncology
Published: April 19, 2019

Transcriptomics in RCC.

Transcriptomics in RCC.

Journal: Urologic oncology
Published: February 05, 2019

Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival.

Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival.

Journal: Urologic oncology
Published: December 07, 2018

Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection.

Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection.

Journal: Cancer
Published: October 31, 2018

Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.

Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.

Journal: European urology
Published: August 31, 2018

Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.

Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.

Journal: World journal of urology
Published: August 30, 2018
Showing 1-12 of 25

Last Updated: 09/26/2026